Main Article Content


Subdural hemorrhages (SDH) are an important bleeding complication of anticoagulation therapy. It’s increasing in population with the use of total anticoagulant therapy. The gold standard management for SDH is surgery. From the neurosurgery view, we cannot treat SDH and arrhythmia alone with the use of anticoagulant therapy, therefore simultaneously requires good interprofessional collaboration and teamwork. In this study, we report a further case from the neurosurgery field. A fifty-two-year-old man had a history of progressive headache, vomiting, facial asymmetries, and drowsiness resulting in a decrease of consciousness. The patient had history diagnosed with arrhythmia by a cardiologist and routinely consume anticoagulant drug therapy warfarin since three months ago. CT-scan without contrast shows isohyperdens mass with a crescent-shaped appearance at right frontotemporoparietooccipital with thickness >10 mm with midline shift >5 mm to the left. Craniotomy evacuation was performed to completely evacuate the clot instead of burrhole drainage. Further treatment is collaborated with a cardiologist to treat arrhythmia in this patient. General conditions, symptoms, and subdural thickness in this patient decide the management of surgical evacuation. Management of subdural hemorrhage with cardiac complications and the use of anticoagulant therapy requires attention because of the complication may happen. For subacute cases, usually a burrhole drainage is adequate, however, in this patient, we use open craniotomy surgery for CT-scan features consideration. Simultaneously, the anticoagulation therapy was temporarily stopped and going for further echocardiography examination. The patient underwent open craniotomy surgery, followed by good result after surgery. Further follow up to prevent rebleeding is required.


Spontaneous subdural hemorrhage Cardiac arrhythmia Anticoagulant therapy Anticoagulant therapy, Decompressive and evacuation craniotomy

Article Details

How to Cite
Adam, A., Zulkifli, B. F., & Gondowardojo, Y. R. (2020). Open craniotomy surgery for subacute spontaneous subdural hemorrhage with anticoagulation therapy in cardiac arrhythmia. Neurologico Spinale Medico Chirurgico, 3(2), 50-54.


  1. Cagetti B, Cossu M, Pau A, et al. The outcome from acute subdural and epidural intracranial haematomas in very elderly patients. Br J Neurosurg. 1992;6:227–31. DOI: 10.3109/02688699209002930.
  2. Koç RK, Akdemir H, Oktem IS, et al. Acute SDH: Outcome and outcome prediction. Neurosurg Rev. 1997;20:239–44. DOI: 10.1007/BF01105894.
  3. Mulligan P, Raore B, Liu S, et al. Neurological and functional outcomes of SDH evacuation in patients over 70 years of age. J Neurosci Rural Pract. 2013;4(3):250–6. DOI: 10.4103/0976-3147.118760.
  4. Gaist D, Rodríguez LAG, Hellfritzsch M, et al. Association of antithrombotic drug use with SDH risk. JAMA. 2017;317(8):836–46. DOI: 10.1001/jama.2017.0639.
  5. Howard MA III, Gross AS, Dacey RG Jr, et al. Acute SDHs: An age-dependent clinical entity. J Neurosurg. 1989;71:858–63. DOI: 10.3171/jns.1989.71.6.0858.
  6. Phuenpathom N, Choomuang M, Ratanalert S. Outcome and outcome prediction in acute SDH. Surg Neurol. 1993;40(1):22–5. DOI:10.1016/0090-3019(93)90164-V.
  7. Won SY, Konczalla J, Dubinski D, et al. A systematic review of epileptic seizures in adults with subdural haematomas. Seizure. 2017;45:28–35. DOI: 10.1016/j.seizure.2016.11.017.
  8. Stein PD, Grandison D, Hua TA, et al. Therapeutic levels of oral anticoagulation with warfarin in patients with mechanical prosthetic heart valves: Review of literature and recommendations based on INR. Postgrad Med J. 1994;70(Suppl1):S72-85.
  9. Hart RG, Boop BS, Anderson DC. OATs and ICH. Stroke. 1995;26:1471-7. DOI: 10.1161/01.STR.26.8.1471.
  10. Wintzen AR, Tijssen JGP. SDH and OAT therapy. Arch Neurol. 1982;39(2):69-72. DOI: 10.1001/archneur.1982.00510140003001.
  11. Taborski U, Müller-Berghaus G. State-of-the-art patient self-management for control of oral anticoagulation. Semin Thromb Hemost. 1999;25(1):43–7. DOI: 10.1055/s-2007-996423.
  12. Connolly BJ, Pearce LA, Hart RG. Vitamin K antagonists and risk of SDH: Meta-analysis of randomized clinical trials. Stroke. 2014;45(6):1672–8. DOI: 10.1161/STROKEAHA.114.005430.
  13. Hylek EM. Complications of OAT therapy: Bleeding and nonbleeding, rates and risk factors. Semin Vasc Med. 2003;03(3):271–8. DOI: 10.1055/s-2003-44463.
  14. Bertram M, Bonsanto M, Hacke W, et al. Managing the therapeutic dilemma: Patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol. 2000;247(3):209–14. DOI: 10.1007/s004150050565.
  15. Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344(19):1450–60. DOI: 10.1056/NEJM200105103441907.
  16. Claassen DO, Kazemi N, Zubkov AY, et al. Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage. Arch Neurol. 2008;65(10):1313–8. DOI: 10.1001/archneur.65.10.1313.
  17. Mattle H, Kohler S, Huber P, et al. Anticoagulation-related intracranial extracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1989;52(7):829–37. DOI: 10.1136/jnnp.52.7.829.
  18. Rust T, Kiemer N, Erasmus A. Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy. J Clin Neurosci. 2006;13(8):823–7 DOI: 10.1016/j.jocn.2004.12.013.
  19. Chai-Adisaksopha C, Hillis C, Siegal DM, et al. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis. Thromb Haemost. 2016;116(05):879–90. DOI: 10.1160/TH16-04-0266.
  20. Desborough MJR, Oakland KA, Landoni G, et al. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: A systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost. 2017;15(2):263–72. DOI:
  21. Greenberg MS. Handbook of neurosurgery. 8th edition. New York: Thieme. 2016.
  22. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–5. DOI: 10.1001/jama.285.18.2370.
  23. Radberg JA, Olsson JE, Radberg CT. Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke. 1991;22:571–6. DOI: 10.1161/01.str.22.5.571.
  24. Fujimoto K, Otsuka T, Yoshizato K, et al. Predictors of rapid spontaneous resolution of acute SDH. Clin Neurol Neurosurg. 2014;118:94-7. DOI: 10.1016/j.clineuro.2013.11.030.
  25. Aguilar MI, Hart RG, Kase CS, et al. Treatment of warfarin-associated intracerebral hemorrhage: Literature review and expert opinion. Mayo Clin Proc. 2007;82(1):82-92. DOI: 10.4065/82.1.82.
  26. Hawryluk GW, Furlan JC, Austin JW, et al. Survey of neurosurgical management of central nervous system hemorrhage in patients receiving anticoagulation therapy: Current practice is highly variable and may be suboptimal. World Neurosurg. 2011;76(3-4):299-303. DOI: 10.1016/j.wneu.2011.03.034.
  27. Phan TG, Koh M, Wijdicks EF. Safety of discontinuation of anticoagulation in patients with ICH at high thromboembolic risk. Arch Neurol. 2000;57(12):1710-3. DOI: 10.1001/archneur.57.12.1710.
  28. De Vleeschouwer S, Van Calenbergh F, van Loon J, et al. Risk analysis of thrombo-embolic and recurrent bleeding events in the management of intracranial haemorrhage due to oral anticoagulation. Acta Chir Belg. 2005;105(3):268-74. DOI: 10.1080/00015458.2005.11679715.
  29. Goldstein JN, Fazen LE, Wendell L, et al. Risk of thromboembolism following acute intracerebral hemorrhage. Neurocrit Care. 2009;10:28-34. DOI: 10.1007/s12028-008-9134-3.
  30. Tahsim-Oglou Y, Beseoglu K, Hanggi D, et al. Factors predicting recurrence of chronic subdural haematoma: The influence of intraoperative irrigation and lowmolecular- weight heparin thromboprophylaxis. Acta Neurochir (Wien). 2012;154:1063-7 [discussion: 1068]. DOI: 10.1007/s00701-012-1334-0.
  31. Yeon JY, Kong DS, Hong SC. Safety of early warfarin resumption following burr hole drainage for warfarin-associated subacute or chronic subdural hemorrhage. J Neurotrauma. 2012;29(7):1334-41. DOI: 10.1089/neu.2011.2074.
  32. Takeuchi S, Takasato Y, Otani N, et al. Subacute subdural hematoma. In: Katayama Y, Maeda T, Kuroiwa T (eds). Brain Edema XV. Acta Neurochirurgica Supplement. Vienna: Springer, 2013;118:143-6.
  33. Acta Neurochirurgica Supplement, Vol. 118, DOI 10.1007/978-3-7091-1434-6_26, © Springer-Verlag Wien 2013
  34. Justin Q, M. et al. Subudural hematom. Radiology Corner. Military Medicine, Vol 171, July. 2006.